Harpoon stock: buy or sell?

HARP stock price: $18.93 5.64% At close on December 6th, 2019

Updated on:
December 6th, 2019


Harpoon Therapeutics climbed 5.64% today to $18.93 after topping to all time highs today. On Monday HARP plunged a scary -9.87%.

Should I buy Harpoon stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Harpoon stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean HARP will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Harpoon stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we collected 4 ratings published for HARP stock in the last month.

The general sentiment of these ratings is bullish for HARP stock, with 4 positive ratings.
Is HARP a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-3-5Canaccord Genuityn/aBuy

Harpoon stock analysis

Daily outlook

After marking all time highs today, Harpoon climbed 5.64% today to $18.93.

Harpoon topped new all time highs back again today, setting highs to $21.26. Shares closed at $18.93 and climbed 5.64%. From a daily perspective, HARP is in a short term uptrend after plotting its last bottom ($13.00, on November 18th) higher than the previous bottom, and its last top ($19.99, on Nov 29th) also over the previous top. Now trading in between its last bottom and last top HARP might consolidate in a plain range, waiting to break out over $19.99 or down under $13.00. On Monday, SMA50d and SMA100d crossed up triggering a rise of 1.23%. Since price and SMA100d lines crossed up on Nov 19th, HARP climbed $5.15 (37.37%).

HARP stock chart (daily)

Weekly outlook

After boosting an exceptional 20.59% in a week last week, Harpoon Therapeutics closed this week at $18.93 and inched a slightly good 1.23%. This week was the 4th green week in a row. Early November HARP plummed a scary -6.24% in just one week.

HARP shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom by mid October, HARP climbed unceasignly breaking out to new all time highs. It touched new all-time highs back again this week, topping to $21.26. By mid November HARP price bounced up over the SMA of 40 weeks that acted as support stopping new slides.

HARP stock chart (weekly)

Harpoon stock price history

Harpoon IPO was on February at $14.00 per share1. Since then, HARP stock grew a 35.20%, with a yearly average of inf%. If you had invested $1,000 in Harpoon stock in 2019, it would worth $352.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Harpoon stock historical price chart

HARP stock reached all-time highs today with a price of $21.26.

Harpoon stock price target is $23.30

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We detected 4 price targets for Harpoon Therapeutics stock published in the last 30 days:
HARP stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-3-5Canaccord GenuityInitiatesn/a$24.00-
(in average)$0.00$23.300.0%
The price forecast for Harpoon stock is $23.30, moving in a range between $24.00 and $23.00. In average, analysts' outlook on HARP price target is stable from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After presenting its last earnings report on March, Harpoon Therapeutics . Unfortunately, reported EPS is not yet available in our database.
HARP earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual turnover report draw an exceptional growth of 570.90% to $4.75 M dollars. Likewise, its profit margin (compared to sales) skyrocketed to -576.13%, that is $-27.37 million.

HARP annual Sales and Income evolution
2017$0.71 M-$-16.83 M-2377.1%-
2018$4.75 M570.90%$-27.37 M-576.1%62.60%

Quarterly financial results

Harpoon posted $1.06 M in revenues for 2018-Q4, a inf% improvement compared to previous quarter. Reported quarter earnings marked $-9.73 M with a profit margin of -916.29%. Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was nan%. When comparing revenues to same quarter last year, Harpoon Therapeutics sales marked an extraordinary increase and boosted a 50.00%.
HARP quarterly Sales and Income evolution
2017-Q4$0.71 M-$-4.94 M-697.7%-
2018-Q4$1.06 M50.00%$-9.73 M-916.3%96.98%

Harpoon ownership

When you are planning to invest in shares of a company, it's always worth to overview its ownership structure.

Harpoon Therapeutics shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 29.85% of all shares.

In case of Harpoon Therapeutics stock, 41.36% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for HARP stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Harpoon:

Market cap$466.4 M
Total shares24.6 M
Float shares9.6 M
  - Institutional holdings (%)41.4%
  - Insider holdings (%)29.8%
Shares in short selling0.0%

Harpoon summary

Friday, December 6th, 2019
Day range$18.08 - $21.26
Previous close$17.92
Session gain5.64%
Average true range$1.69
50d mov avg$14.38
100d mov avg$14.20
200d mov avg$13.19
Daily patternlt06a
Weekly pattern lb03c

Harpoon performance

To measure stock performance is always good to compare with competitors or related stocks. We compared Harpoon Therapeutics against in the following table:
HARPHarpoon Therapeut...28.17%70.54%0.00%

Harpoon competitors

Unfortunately, we could not find any public company that could be defined as Harpoon competitor. This doesn't mean Harpoon does not have any competitor in the market, it's just we could not detected it.